In his role as compliance officer of a McKesson warehouse in Ohio, David Gustin was responsible for determining whether pharmacies were allowing McKesson’s drugs to be sold on the black market.
The federal lawsuit alleges that Mr. Gustin was so woefully negligent in doing his job that his conduct was criminal, according to The Washington Post.
Federal prosecutors also claim Mr. Gustin conspired to illegally distribute oxycodone, hydrocodone and alprazolam from May 2008 to April 2016.
Read the full report here.
More articles on pharmacy:
Carcinogen concerns prompt Sandoz to halt global distribution of heartburn drug
FDA partnering with other countries to improve access to cancer drugs
Common antibiotics linked to heart valve problems, study finds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
